Status: Recruiting
Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis
The purpose of this study is to evaluate the safety and efficacy of GP-asPNA for in vivo treatment of severe antibiotic resistant bacterial keratitis.
Participants needed: 20
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Eye & ENT Hospital of Fudan UniversityUpdated: Jun 11, 2024Locations: 1
Eligibility criteria
The results of antimicrobial susceptibility testing in patients with bacterial k... [+5]
Lacrimal coating and blink function loss. [+23]